Fangchinoline targets epithelial–mesenchymal transition process by modulating activation of multiple cell‐signaling pathways
- 27 May 2022
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 123 (7) , 1222-1236
Abstract
Epithelial–mesenchymal transition (EMT) is a key process, which can promote the transition of tumor cells into other organs by weakening the cell‐cell junctions. Tumor cell invasion and metastasis arising because of EMT can determine the prognosis of cancer. EMT can be induced by several growth factors including transforming growth factor‐β (TGF‐β), which can exert their effects by affecting several cell‐signaling pathways. Fangchinoline (FCN), a kind of bisbenzylisoquinoline, belongs to the family Menispermaceae. FCN can display substantial antitumor effects against various malignant cell lines but its possible impact on EMT has not been explored. We examined the potential impact of FCN in affecting the activation of EMT in human colon cancer cells. We evaluated the influence of FCN on EMT in colon cancer cells by using Western blot analysis and reverse transcription‐polymerase chain reaction assays. The cellular invasion and migration were observed by Boyden chamber and wound healing assays. Thereafter, the effect of the drug on proliferation and invasion was also evaluated by real‐time cell analysis. FCN suppressed the levels of TGF‐β‐induced mesenchymal markers, such as fibronectin, vimentin, MMP‐9, MMP‐2, N‐cadherin, Twist, and Snail. However, FCN markedly enhanced the expression of epithelial markers such as occludin and E‐cadherin. These results imply that FCN can potentially inhibit tumor metastasis through abrogating EMT. In addition, FCN downregulated c‐Met/PI3K/Akt/mTOR and Wnt/β‐catenin cell signaling pathways and mitigated tumor migration as well as invasion. Overall, our study suggests a potential novel role of FCN as an antimetastatic agent against human colon cancer cells.Keywords
Funding Information
- National Research Foundation of Korea (NRF‐2021R1I1A2060024, NRF‐2022R1I1A1A01071593)
This publication has 69 references indexed in Scilit:
- Epithelial Mesenchymal Transition in Drug Resistance and Metastasis of Lung CancerCancer Research and Treatment, 2012
- GSK3: a multifaceted kinase in Wnt signalingTrends in Biochemical Sciences, 2010
- Epithelial-mesenchymal transitions: the importance of changing cell state in development and diseaseJournal of Clinical Investigation, 2009
- TGFβ in CancerCell, 2008
- Evolution of the Wnt Pathways2008
- Salinosporamide A (NPI-0052) potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through down-modulation of NF-κB–regulated gene productsBlood, 2007
- Epithelial to Mesenchymal Transition Is a Determinant of Sensitivity of Non–Small-Cell Lung Carcinoma Cell Lines and Xenografts to Epidermal Growth Factor Receptor InhibitionCancer Research, 2005
- The Akt-mTOR tango and its relevance to cancerCancer Cell, 2005
- Upstream and downstream of mTORGenes & Development, 2004
- Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor MetastasisCell, 2004